Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Jacobs

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|October 1, 1996
Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diaryJ M van Gerven, R C Schoemaker, L D Jacobs, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburnR A Faaij, J M Van Gerven, I Jolivet-Landreau, et al.
The New England Journal of Medicine|September 28, 2000
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study GroupL D Jacobs, R W Beck, J H Simon, et al.
Clinical and Diagnostic Laboratory Immunology|January 1, 1997
Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locusS J Greenberg, K Fujihara, S M Selkirk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Neurology|January 3, 2001
Are quantitative functional measures more sensitive to worsening MS than traditional measures?S R Schwid, A D Goodman, B R Apatoff, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 1999
A profile of multiple sclerosis: the New York State Multiple Sclerosis ConsortiumL D Jacobs, K E Wende, C M Brownscheidle, et al.
Neurology|May 22, 1998
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, N A Simonian, J A Alam, et al.
Neurology|July 17, 1999
A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)J H Simon, L D Jacobs, M K Campion, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|October 1, 1996
Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diaryJ M van Gerven, R C Schoemaker, L D Jacobs, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburnR A Faaij, J M Van Gerven, I Jolivet-Landreau, et al.
The New England Journal of Medicine|September 28, 2000
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study GroupL D Jacobs, R W Beck, J H Simon, et al.
Clinical and Diagnostic Laboratory Immunology|January 1, 1997
Novel compound tetra-, dinucleotide microsatellite polymorphism in the tumor necrosis factor/lymphotoxin locusS J Greenberg, K Fujihara, S M Selkirk, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Neurology|January 3, 2001
Are quantitative functional measures more sensitive to worsening MS than traditional measures?S R Schwid, A D Goodman, B R Apatoff, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 1999
A profile of multiple sclerosis: the New York State Multiple Sclerosis ConsortiumL D Jacobs, K E Wende, C M Brownscheidle, et al.
Neurology|May 22, 1998
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, N A Simonian, J A Alam, et al.
Neurology|July 17, 1999
A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)J H Simon, L D Jacobs, M K Campion, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Pageof 4